What are the side effects of dordaviprone-Modeyso?
Dordaviprone (dordaviprone) - Modeyso is an agent indicated for the treatment of diffuse midline glioma, specifically in adults and pediatric patients 1 year of age and older who have progressive disease with the H3 K27M mutation. The drug works by activating the mitochondrial caseinolytic protease P (ClpP) while inhibiting dopamine D2 receptors, thereby slowing cancer growth and promoting cancer cell death.
However, there are some side effects that may occur when usingModeyso. Common adverse reactions include fatigue, headache, vomiting, nausea, and musculoskeletal pain. These reactions may affect the patient's quality of life, so patients need to pay close attention to the occurrence and extent of these symptoms during treatment.
On laboratory testing,Modeyso may cause some Grade 3 or 4 abnormalities, including lymphopenia, decreased calcium, and increased alanine aminotransferase (ALT) levels. These laboratory abnormalities require a physician's attention and monitoring because they may reflect a patient's body's response to medications as well as potential health risks.
In addition,Modeyso has some warnings and notes. Use of this drug may cause hypersensitivity or allergic reactions, and patients should inform their doctor of their allergic history before taking the drug. Also be aware of QTc interval prolongation, which may lead to arrhythmias, so electrocardiograms (ECG) should be monitored regularly before use and during treatment. In addition, Modeyso may also have embryo-fetal toxicity, so special caution is required when using it in patients who are pregnant or planning to become pregnant.
In summary, althoughModeyso has significant efficacy in the treatment of diffuse midline glioma, patients need to be alert to possible side effects and adverse reactions during use, and conduct relevant health monitoring regularly to ensure the safety and effectiveness of the treatment. If serious adverse reactions occur, you should communicate with the medical team in time so that appropriate countermeasures can be taken.
Reference materials:https://www.drugs.com/modeyso.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)